GeneReach Biotechnology Corp. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 751.08 million compared to TWD 1,017.56 million a year ago.

Revenue was TWD 750.02 million compared to TWD 1,012.08 million a year ago. Net income was TWD 221.34 million compared to TWD 376.62 million a year ago. Basic earnings per share from continuing operations was TWD 3.856 compared to TWD 6.552 a year ago.

Diluted earnings per share from continuing operations was TWD 3.736 compared to TWD 6.448 a year ago.